CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 42 enrolled
Drug / intervention
FAmily CEntered (FACE) pACP Interventionbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04855734
NCT04855734N/ACompleted

Palliative Care Needs of Children With Rare Diseases and Their Families

Children's National Research Institute·interventional·Posted Apr 22, 2021·Updated May 4, 2025

In Brief

A clinical study evaluating FAmily CEntered (FACE) pACP Intervention for Rare Diseases. Completed, enrolled 42 participants across 1 site.

Detailed Summary

Children with ultra-rare or complex rare diseases are routinely excluded from research studies because of their conditions, creating a health disparity. However, new statistical techniques make it possible to study small samples of heterogeneous populations. We propose to study the palliative care needs of family caregivers of children with ultra-rare diseases and to pilot test a palliative care needs assessment and advance care planning intervention to facilitate discussions about the future medical care choices families are likely to be asked to make for their child.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRare Diseases
CountriesUnited States

Timeline

N/ACompletedFinished
20222023202420252026
First PostedApr 22, 2021
Enrollment StartJul 6, 2021
Primary CompletionDec 31, 2023
Study CompletionJun 1, 2024
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 5.2 years ago

Interventions

FAmily CEntered (FACE) pACP Interventionbehavioral

The (approximately) weekly 3-session FACE-Rare intervention of approximately 45-60 minutes each is comprised of the CSNAT approach \[Sessions 1 \& 2\] and Respecting Choices \[Session 3\].